Project 2VIDA! SARS-CoV-2 Vaccine Intervention Delivery for Adults in Southern California

项目2VIDA！

• 批准号: 10551898
• 负责人: Argentina Elisa Noelle Servin
• 金额: $ 58.45万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-04-23 至 2026-01-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10551898
• 关键词: 18 year old; Acceleration; Address; Adult; Affect; African American; Area; Awareness; Behavior; Belief; Biological Factors; COVID-19; COVID-19 impact; COVID-19 mortality; COVID-19 vaccination; COVID-19 vaccine; California; Centers for Disease Control and Prevention (U.S.); Cessation of life; Characteristics; Client satisfaction; Communities; Community Health; Community Outreach; Community Participation; Country; County; Data; Education; Equity; Essential worker; Fright; Genetic; Geographic Locations; Government; Handwashing; Health; Health Promotion; Healthcare; Home; Human Rights; Immunization; Immunization Programs; Individual; Infection; Intervention; Knowledge; Latino; Latinx; Latinx population; Masks; Medical; Methods; Modeling; Nature; Neighborhood Health Center; Not Hispanic or Latino; Occupations; Outcome; Participant; Perception; Persons; Phase; Policies; Population; Prevention; Preventive; Randomized, Controlled Trials; Recommendation; Recording of previous events; Reporting; Research; Risk; Series; Services; Site; Social Distance; Strategic Planning; Trust; United States; United States National Institutes of Health; Vaccination; Vaccines; Virus; Vulnerable Populations; World Health Organization; acceptability and feasibility; adverse outcome; community based participatory research; comparison control; contextual factors; demographics; ethnic minority; evidence base; experience; follow-up; health care availability; health care service utilization; health disparity; health disparity populations; hospitalization rates; implementation intervention; improved; indicated prevention; infection rate; interest; intervention delivery; intervention effect; intervention refinement; marginalization; pandemic disease; pandemic impact; participant retention; people of color; prevent; racial minority; racism; recruit; satisfaction; scale up; social; social factors; sociodemographics; standard of care; uptake; vaccination protocol; vaccine acceptance; vaccine access; vaccine hesitancy; working group

PROJECT SUMMARY As of January 2021, the World Health Organization (WHO) reports that 89 million cases of COVID-19 (SARS- CoV-2) have been confirmed and have resulted in more than 1.9 million deaths globally. Currently, the United States (U.S.) is the country with the largest number of infections and deaths due to COVID-19, with a total of 22 million infections and 373,167 deaths. Furthermore, early findings that have examined COVID-19 demographics show that racial and ethnic minorities in the U.S. are bearing a disproportionate number of COVID-19 cases and deaths irrespective of geographic region. While there's no evidence that people of color (POC) have genetic or biological factors that make them more likely to be affected by COVID-19, they are more likely to have underlying health conditions, live in multi-generational homes, live in densely populated areas, have limited access to healthcare, and have jobs that are considered essential and involve interaction with the public. All of these factors contribute to higher rates of infection and adverse outcomes due to COVID-19. Although COVID-19 preventive behaviors such as hand washing, mask wearing, and social distancing have been shown to be effective in curbing the spread of the virus, acceptance and uptake of COVID-19 vaccines will be instrumental to ending the pandemic. However, public confidence in vaccination is fragile, especially among racial and ethnic minorities. To this end, we have formed an intervention working group comprised of representatives from community and academic organizations to address challenges in COVID-19 vaccination uptake among Latinx and African American (AA) communities in Southern California by using a community-based participatory research (CBPR) approach. Project 2VIDA! (SARS-CoV-2 Vaccine Intervention Delivery for Adults in Southern California), is a multilevel intervention to address individual, social, and contextual factors related to access to, and acceptance of, the COVID-19 vaccine among Latinx and AA adults (>18 years old) across six highly affected communities in Southeast San Diego. 2VIDA! seeks to implement and assess a COVID-19 vaccination protocol to increase interest and uptake of COVID-19 vaccine, provide COVID-19 vaccines in the community, and establish a model for the rapid vaccination of Latino and AA adults that could be generalizable to other highly affected communities. 2VIDA! builds on our previous CBPR efforts and centers on conducting COVID-19 community outreach and health promotion, Individual awareness and education, and linkages to medical and supportive services and offering the COVID-19 vaccine to Latinx and AA adults (>18 years old) in community health centers (CHC) and mini-vaccination stations in communities highly impacted by the pandemic in San Diego County.

项目摘要 截至2021年1月，世界卫生组织（世卫组织）报告称，8900万例COVID-19（SARS- CoV-2）已被证实，并导致全球190多万人死亡。目前联合 州（美国）是因COVID-19感染和死亡人数最多的国家，共有 2200万人感染，373,167人死亡。此外，研究COVID-19的早期发现 人口统计数据显示，美国的种族和少数民族正在承受不成比例的人口增长。 COVID-19病例和死亡，不分地理区域。虽然没有证据表明有色人种 (POC)有遗传或生物因素使他们更容易受到COVID-19的影响，他们是 更有可能有潜在的健康状况，生活在多代同堂的家庭中，生活在人口稠密的 地区，获得医疗保健的机会有限，工作被认为是必不可少的，需要互动 与公众。所有这些因素导致COVID-19的感染率和不良后果增加。虽然COVID-19预防行为，如洗手，戴口罩和社交距离 已被证明在遏制病毒传播、接受和吸收COVID-19方面有效 疫苗将有助于结束这一流行病。然而，公众对疫苗接种的信心是脆弱的， 特别是在少数民族和种族之间。为此，我们成立了干预工作小组 由来自社区和学术组织的代表组成，以应对COVID-19的挑战 在南加州的拉丁裔和非洲裔美国人（AA）社区中， 社区参与式研究（CBPR）。2 VIDA计划！（SARS-CoV-2疫苗干预 加州南部的成人分娩），是一种多层次的干预措施，以解决个人，社会， 与拉丁裔和AA成年人获得和接受COVID-19疫苗相关的背景因素 （>18岁）在圣地亚哥东南部的六个高度受影响的社区。2维达！旨在实施 并评估COVID-19疫苗接种方案，以增加对COVID-19疫苗的兴趣和使用， 在社区接种COVID-19疫苗，并建立拉丁裔和AA成年人快速接种疫苗的模式 这可以推广到其他受影响严重的社区。2维达！基于我们之前的CBPR工作 并专注于开展COVID-19社区外展和健康促进，个人意识和 教育，与医疗和支持服务的联系，并向拉丁美洲提供COVID-19疫苗， 社区卫生中心和社区小型疫苗接种站的成年AA（>18岁） 受到圣地亚哥县大流行的严重影响。